Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Retained Earnings of $336.1 million in Q1 2026, up 374.67% quarter-over-quarter from -$122.4 million in Q4 2025, and up 356.25% on a YoY basis from $73.7 million in Q1 2025.
Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026) Analysis & Trends
Phibro Animal Health's Retained Earnings history runs 14 years deep, the most recent figure standing at $336.1 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 356.25% year-over-year to $336.1 million; the TTM figure through Mar 2026 stood at $336.1 million (up 356.25% YoY), while the FY2025 annual figure was -$124.0 million, down 150.85% from the prior year.
- Retained Earnings was $336.1 million for Q1 2026 at Phibro Animal Health, up from -$122.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $336.1 million in Q1 2026 to a low of -$131.2 million in Q1 2025.
- Historically, Retained Earnings has averaged $60.3 million across 5 years, with a median of -$114.0 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings slumped 155.4% in 2022, then soared 356.25% in 2026.
- A 5-year view of Retained Earnings shows it stood at $249.1 million in 2022, then slipped by 1.86% to $244.4 million in 2023, then dropped by 0.05% to $244.3 million in 2024, then tumbled by 150.08% to -$122.4 million in 2025, then jumped by 374.67% to $336.1 million in 2026.
- The last three Retained Earnings figures came in at $336.1 million (Q1 2026), -$122.4 million (Q4 2025), and $294.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 336.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336.12 Mn |
| Dec 31, 2025 | -122.37 Mn |
| Sep 30, 2025 | 294.36 Mn |
| Jun 30, 2025 | -124.02 Mn |
| Mar 31, 2025 | -131.17 Mn |
| Dec 31, 2024 | 244.33 Mn |
| Sep 30, 2024 | -123.94 Mn |
| Jun 30, 2024 | 243.89 Mn |
| Mar 31, 2024 | -114.00 Mn |
| Dec 31, 2023 | 244.45 Mn |
| Sep 30, 2023 | 248.04 Mn |
| Jun 30, 2023 | -114.21 Mn |
| Mar 31, 2023 | -117.75 Mn |
| Dec 31, 2022 | 249.09 Mn |
| Sep 30, 2022 | 246.74 Mn |
| Jun 30, 2022 | -121.11 Mn |
| Mar 31, 2022 | -113.98 Mn |
| Dec 31, 2021 | 232.29 Mn |
| Sep 30, 2021 | -122.19 Mn |
| Jun 30, 2021 | -115.29 Mn |